Patents by Inventor Eduard Ayuso López

Eduard Ayuso López has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene therapy composition for use in diabetes treatment
    Patent number: 11001857
    Abstract: New gene therapy constructions and compositions are the subject of present invention. The gene therapy compositions consist in adeno-associated vectors which jointly express insulin (Ins) and glucokinase (Gck) genes. The new gene therapy constructions are useful for treatment of diabetes either in dogs or human beings.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: May 11, 2021
    Assignee: UNIVERSITAT AUTONOMA DE BARCELONA
    Inventors: Fátima Bosch Tubert, Eduard Ayuso López, David Callejas Casti{tilde over (η)}eiras
  • GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT
    Publication number: 20200216861
    Abstract: New gene therapy constructions and compositions are the subject of present invention. The gene therapy compositions consist in adeno-associated vectors which jointly express insulin (Ins) and glucokinase (Gck) genes. The new gene therapy constructions are useful for treatment of diabetes either in dosgs or human beings.
    Type: Application
    Filed: February 27, 2020
    Publication date: July 9, 2020
    Applicant: Universitat Autònoma de Barcelona
    Inventors: Fàtima Bosch Tubert, Eduard Ayuso López, Callejas Castiñeiras David
  • Gene therapy composition for use in diabetes treatment
    Patent number: 9309534
    Abstract: New gene therapy constructions and compositions are the subject of present invention. The gene therapy compositions consist in adeno-associated vectors which jointly express insulin (Ins) and glucokinase (Gck) genes. The new gene therapy constructions are useful for treatment of diabetes either in dogs or human beings.
    Type: Grant
    Filed: July 12, 2011
    Date of Patent: April 12, 2016
    Assignee: UNIVERSIDAD AUTONOMA DE BARCELONA
    Inventors: Fátima Bosch Tubert, Eduard Ayuso López, David Callejas Castiñeiras
  • GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT
    Publication number: 20160074534
    Abstract: New gene therapy constructions and compositions are the subject of present invention. The gene therapy compositions consist in adeno-associated vectors which jointly express insulin (Ins) and glucokinase (Gck) genes. The new gene therapy constructions are useful for treatment of diabetes either in dogs or human beings.
    Type: Application
    Filed: November 25, 2015
    Publication date: March 17, 2016
    Inventors: Fátima BOSCH TUBERT, Eduard AYUSO LÓPEZ, David CALLEJAS CASTIÑEIRAS
  • Vectors and sequences for the treatment of diseases
    Patent number: 9279132
    Abstract: The present invention provides new sequences, gene constructions, vectors and pharmaceutical compositions for the treatment of diseases and specially, for the treatment of mucopolysaccharidoses.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: March 8, 2016
    Assignees: LABORATORIOS DEL DR. ESTEVE, S.A., UNIVERSIDAD AUTONOMA DE BARCELONA
    Inventors: Fátima Bosch Tubert, Éduard Ayuso López, Albert Ruzo Matías
  • VECTORS AND SEQUENCES FOR THE TREATMENT OF DISEASES
    Publication number: 20150104863
    Abstract: The present invention provides new sequences, gene constructions, vectors and pharmaceutical compositions for the treatment of diseases and specially, for the treatment of mucopolysaccharidoses.
    Type: Application
    Filed: November 3, 2014
    Publication date: April 16, 2015
    Inventors: Fátima Bosch Tubert, Éduard Ayuso López, Albert Ruzo Matías
  • Vectors and sequences for the treatment of diseases
    Patent number: 8999948
    Abstract: The present invention provides new sequences, gene constructions, vectors and pharmaceutical compositions for the treatment of diseases and specially, for the treatment of mucopolysaccharidoses.
    Type: Grant
    Filed: June 10, 2011
    Date of Patent: April 7, 2015
    Assignees: Laboratorios del Dr. Esteve, S.A., Universidad Autonoma de Barcelona
    Inventors: Fátima Bosch Tubert, Éduard Ayuso López, Albert Ruzo Matías
  • GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT
    Publication number: 20140342982
    Abstract: New gene therapy constructions and compositions are the subject of present invention. The gene therapy compositions consist in adeno-associated vectors which jointly express insulin (Ins) and glucokinase (Gck) genes. The new gene therapy constructions are useful for treatment of diabetes either in dogs or human beings.
    Type: Application
    Filed: July 12, 2011
    Publication date: November 20, 2014
    Applicant: UNIVERSIDAD AUTÓNOMA DE BARCELONA
    Inventors: Fátima Bosch Tubert, Eduard Ayuso López, David Callejas Castiñeiras
  • VECTORS AND SEQUENCES FOR THE TREATMENT OF DISEASES
    Publication number: 20130158104
    Abstract: The present invention provides new sequences, gene constructions, vectors and pharmaceutical compositions for the treatment of diseases and specially, for the treatment of mucopolysaccharidoses.
    Type: Application
    Filed: June 10, 2011
    Publication date: June 20, 2013
    Applicants: Laboratorios Del DR Esteve S.A, Universidad Autonoma De Barcelona
    Inventors: Fátima Bosch Tubert, Éduard Ayuso López, Albert Ruzo Matías